Skip to main content
. 2019 May 22;21(4):66. doi: 10.1208/s12248-019-0332-z

Fig. 2.

Fig. 2

a Serum and b tumor PK profiles of PF-06671008 in PBMC engrafted and non-PBMC engrafted HCT-116 tumor-bearing mice following single-dose intravenous administration at 0.05 and 0.5 mg/kg